Hypertension Circulatory System Hypertension
Conditions
Interventions
The study adopts a cluster randomized controlled trial (RCT) design involving a total of 60 site communities with 12 in the control arm and 48 in the intervention arm. The control arm maintains existi
while the intervention arms, personalized hypertension management (PHMA). Project evaluation applies to all arms using the same data collection methods and by the same field data collectors. And detai
Sponsors
National Natural Science Foundation of China
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged =18 years 2. Living in the selected villages for =6 months/year 3. Diagnosed with hypertension
Exclusion criteria
Exclusion criteria: Previous diagnosis of mental illness, serious illness, or disability
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic BP/Diastolic BP measured using mercury sphygmomanometer at baseline and every 12 months after baseline for 5 years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quality of life 2. Occurrence of hypertension-related complications (such as cerebral hemorrhage, coronary heart disease, myocardial infarction, cerebral infarction) 3. Healthcare utilization 4. Scores of objective behaviors All secondary outcome measures will be measured using structured questionnaires at baseline and every 12 months after baseline for 5 years | — |
Countries
China
Outcome results
None listed